Villanova Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Villanova Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.62M	Hold	34,934	–	–	1.54%	34
2026 Q1	$1.81M	Sell	34,934 -13,120	-27%	-$668K	1.85%	23
2025 Q4	$2.39M	Sell	48,054 -6,814	-12%	-$331K	1.68%	25
2025 Q3	$2.62M	Buy	54,868 +2,544	+5%	+$102K	1.82%	22
2025 Q2	$1.65M	Buy	52,324 +32,737	+167%	+$1.05M	1.71%	24
2025 Q1	$1.87M	Sell	19,587 -37,445	-66%	-$1.33M	1.85%	21
2024 Q4	$2.06M	Buy	57,032 +5,496	+11%	+$194K	1.84%	23
2024 Q3	$1.61M	Buy	51,536 +58	+0.1%	+$1.81K	1.72%	29
2024 Q2	$1.38M	Buy	+51,478	New	+$1.49M	1.46%	33

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Villanova Investment Management's SUPN Position: Q2 2026 in Review

Villanova Investment Management held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 34,934 shares worth $1.62M. The position accounts for 1.54% of the portfolio, ranked #34.

Villanova Investment Management first reported a position in SUPN in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.62M in Q3 2025. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Villanova Investment Management held 34,934 shares of Supernus Pharmaceuticals worth $1.62M as of Q2 2026.
Villanova Investment Management left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
Supernus Pharmaceuticals made up 1.54% of Villanova Investment Management's portfolio in Q2 2026, its #34 holding.
Villanova Investment Management first reported a position in Supernus Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Villanova Investment Management's Supernus Pharmaceuticals position peaked at $2.62M in Q3 2025.
332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Villanova Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.